Pharmacology & Toxicology · 1996 · 24 citations · 19 references
MedicineHematologyPharmacologyBiochemical PharmacologyHemostasisPharmacodynamicsAntiplatelet TherapyPlatelet ActivationPlatelet AdhesionPlatelet AggregationPlatelet FunctionPlatelet PhysiologyAdenosine Diphosphate-induced Platelet AggregationAntiplatelet Drug MechanismsAntiplatelet DrugsArachidonic Acid SignalingPlatelet Aggregation InhibitionPlatelet InhibitionPlatelet Responses To AgonistsWashed Platelets
We investigated the effect on human platelet aggregation of the naturally occurring quinone/hydroquinone couple, avarone and avarol. Avarone exerted antiplatelet activity both on platelet-rich plasma and, to a greater extent, on washed platelets. The quinone inhibited the platelet aggregatory process with all the agonists used. The highest inhibitory potency occurred with arachidonic acid or A23187 as stimulating agents. In the case of agonists such as adenosine 5' diphosphate, platelet-activating factor or U46619, the antiaggregatory effect was more pronounced on the second wave. Inhibition of the aggregatory process paralleled thromboxane B2 formation. Avarol also exerted antiplatelet activity, even though its inhibitory potency was much lower than that of avarone.
19
Superoxide anions enhance platelet adhesion and aggregation
Daniela Salvemini, Gilberto De Nucci, J M Sneddon et al. · British Journal of Pharmacology · 1989 · 136 citations · Full text
Medicine, Biochemistry, Cell Biology +17